| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 2.14e-11 | 37 | 172 | 9 | GO:0004190 |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 2.78e-11 | 38 | 172 | 9 | GO:0070001 |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 USP9X ERVK-7 ERVK-21 ERVK-9 PIK3IP1 LPA ERVK-8 ERVK-18 PAPPA ERVK-19 ERVK-25 ERVK-24 | 9.40e-05 | 430 | 172 | 13 | GO:0004175 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 9.85e-05 | 11 | 172 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 2.13e-04 | 14 | 172 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | DMTF1 HHEX ZFAT FOSL2 MECOM IRF2 ZNF395 ATF6B TFAP4 KLF9 BARHL2 ELK1 DMRT1 ZNF292 | 3.63e-04 | 560 | 172 | 14 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | DMTF1 HHEX ZFAT FOSL2 MECOM IRF2 ZNF395 ATF6B TFAP4 KLF9 BARHL2 ELK1 DMRT1 ZNF292 | 4.03e-04 | 566 | 172 | 14 | GO:0001216 |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 TANK USP9X ERVK-7 ERVK-21 ERVK-9 PIK3IP1 LPA ERVK-8 ERVK-18 PAPPA ERVK-19 USP35 ERVK-25 ERVK-24 | 5.52e-04 | 654 | 172 | 15 | GO:0008233 |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 7.45e-04 | 21 | 172 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | RALGDS DENND4A RASGRF2 LAMTOR5 ARHGEF10 KNDC1 AKAP13 RAPGEF2 | 9.02e-04 | 231 | 172 | 8 | GO:0005085 |
| GeneOntologyBiologicalProcess | cell-cell fusion | 5.30e-07 | 85 | 171 | 8 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 5.30e-07 | 85 | 171 | 8 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 7.56e-07 | 89 | 171 | 8 | GO:0006949 | |
| GeneOntologyBiologicalProcess | viral process | ERVK-6 LAMTOR5 WWP1 ERVK-7 ERVK-21 ERVK-9 TFAP4 TNFRSF4 ERVK-8 ERVK-5 ERVK-19 CTBP2 SIGLEC1 ERVK-24 | 3.41e-05 | 464 | 171 | 14 | GO:0016032 |
| GeneOntologyBiologicalProcess | interkinetic nuclear migration | 6.44e-05 | 10 | 171 | 3 | GO:0022027 | |
| Domain | RasGEFN | 2.26e-05 | 20 | 160 | 4 | SM00229 | |
| Domain | RasGEF_N | 2.77e-05 | 21 | 160 | 4 | PF00618 | |
| Domain | Ras-like_Gua-exchang_fac_N | 3.36e-05 | 22 | 160 | 4 | IPR000651 | |
| Domain | RASGEF_NTER | 3.36e-05 | 22 | 160 | 4 | PS50212 | |
| Domain | RASGEF_CAT | 1.04e-04 | 29 | 160 | 4 | PS50009 | |
| Domain | RasGEF | 1.19e-04 | 30 | 160 | 4 | PF00617 | |
| Domain | - | 1.19e-04 | 30 | 160 | 4 | 1.10.840.10 | |
| Domain | RASGEF_cat_dom | 1.19e-04 | 30 | 160 | 4 | IPR001895 | |
| Domain | RasGEF | 1.19e-04 | 30 | 160 | 4 | SM00147 | |
| Domain | Ras_GEF_dom | 1.19e-04 | 30 | 160 | 4 | IPR023578 | |
| Domain | TACC | 2.18e-04 | 3 | 160 | 2 | PF05010 | |
| Domain | TACC | 2.18e-04 | 3 | 160 | 2 | IPR007707 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 2.79e-12 | 5 | 172 | 5 | 12629516 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-8 ERVK-18 ERVK-5 ERVK-19 ERVK-25 ERVK-24 | 4.25e-11 | 94 | 172 | 10 | 21542922 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | JCAD DENND4A PHACTR2 MAP1B MAP3K14 MPDZ CEP192 RAB11FIP1 RFX7 TRAK1 FSIP2 MAST4 ARHGEF10 HELZ AKAP13 RAPGEF2 PLCH1 EIF4G3 ARHGAP21 AQR GAB1 | 2.09e-09 | 861 | 172 | 21 | 36931259 |
| Pubmed | 2.15e-09 | 12 | 172 | 5 | 14557543 | ||
| Pubmed | 2.27e-08 | 18 | 172 | 5 | 18664271 | ||
| Pubmed | PALD1 MOSPD2 TANK ZFYVE16 UBAP1 MPDZ MECOM FNDC3A TSC1 ICE1 LARP4 ITPR2 YEATS2 ARHGEF10 HELZ AKAP13 RPRD2 PLCH1 | 2.88e-08 | 733 | 172 | 18 | 34672954 | |
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 10516026 | ||
| Pubmed | ZFAT SFSWAP USP9X MTSS1 GEMIN5 RFX7 KLF9 MKI67 HELZ AKAP13 AQR ZNF292 | 1.25e-07 | 335 | 172 | 12 | 15741177 | |
| Pubmed | AFF2 SFSWAP TCOF1 CCDC30 CEP192 AKAP12 BBX ATF7IP PPP1R15B CD44 MKI67 TACC3 RAPGEF2 EIF4G3 ARHGAP21 GAB1 XPO7 | 3.62e-07 | 777 | 172 | 17 | 35844135 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 4.74e-07 | 4 | 172 | 3 | 10469592 | |
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 7983737 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PALD1 KIF26A WWP1 FOSL2 PIEZO1 GEMIN5 ICE1 CEP192 ZNF395 MDFI PIP5K1C TRAK1 ITPR2 PCNX2 INF2 PLEKHO2 PPP1R15B AKAP13 IL4R ARHGAP21 | 6.45e-07 | 1105 | 172 | 20 | 35748872 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | DMTF1 HHEX ZBTB38 PHF20 LCORL FOSL2 ASH1L IRF2 ZNF395 RFX7 ATF6B TFAP4 YEATS2 BBX KLF9 BARHL2 ELK1 DMRT1 | 6.72e-07 | 908 | 172 | 18 | 19274049 |
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 1.18e-06 | 5 | 172 | 3 | 11401426 | |
| Pubmed | 1.18e-06 | 5 | 172 | 3 | 28191889 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | DMTF1 JCAD CACNA1S AFF2 SPATA31E1 TCOF1 PIP5K1C ZNF804A XIRP2 AKAP13 EIF4G3 GAB1 | 1.75e-06 | 430 | 172 | 12 | 35044719 |
| Pubmed | 2.35e-06 | 6 | 172 | 3 | 15063128 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 2.56e-06 | 232 | 172 | 9 | 25515538 | |
| Pubmed | RALGDS ZSCAN12 KIF26A PIEZO1 MTSS1 FNDC3A ICE1 ERI2 AFAP1 MAST4 RPRD2 CACNA1G ARHGAP20 | 2.60e-06 | 529 | 172 | 13 | 14621295 | |
| Pubmed | 2.65e-06 | 233 | 172 | 9 | 37704626 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | PALD1 MAP1B ZFYVE16 TCOF1 GEMIN5 TSC1 TACC2 ICE1 AKAP12 YEATS2 ATF7IP MKI67 HELZ RPRD2 EIF4G3 ARHGAP21 TP53BP1 | 4.36e-06 | 934 | 172 | 17 | 33916271 |
| Pubmed | MOSPD2 TCOF1 PIEZO1 BAG4 MPDZ FNDC3A CEP192 RAB11FIP1 ATF6B AKAP12 ITPR2 NOP58 ARHGEF10 INF2 PPP1R15B AKAP13 PLCH1 EIF4G3 DNAJB2 AQR GAB1 TP53BP1 | 4.69e-06 | 1487 | 172 | 22 | 33957083 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | JCAD LCORL RBL1 GEMIN5 MECOM ZNF518A YEATS2 ATF7IP CTBP2 ELK1 ZNF292 | 5.23e-06 | 398 | 172 | 11 | 35016035 |
| Pubmed | 5.68e-06 | 24 | 172 | 4 | 27217206 | ||
| Pubmed | PALD1 ZFYVE16 TSC1 CEP192 PIP5K1C TRAK1 EPG5 YEATS2 ARHGAP21 AQR XPO7 | 6.45e-06 | 407 | 172 | 11 | 12693553 | |
| Pubmed | The Piezo channel is a mechano-sensitive complex component in the mammalian inner ear hair cell. | 6.54e-06 | 8 | 172 | 3 | 38228630 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SFSWAP TCOF1 FOSL2 GEMIN5 RFX7 TFAP4 FBXO38 YEATS2 BRD8 MKI67 ZBTB40 KIAA1958 HELZ TACC3 TP53BP1 | 7.84e-06 | 774 | 172 | 15 | 15302935 |
| Pubmed | ZFYVE16 LCORL GEMIN5 MECOM ICE1 YEATS2 ATF7IP KIAA1958 CTBP2 TACC3 ARHGAP21 | 8.29e-06 | 418 | 172 | 11 | 34709266 | |
| Pubmed | DMTF1 ZFYVE16 WWP1 ASH1L ZNF518A TRAK1 EPG5 MAST4 ATF7IP PPP1R15B PAPPA CTBP2 DNAJB2 | 8.58e-06 | 591 | 172 | 13 | 15231748 | |
| Pubmed | TCOF1 USP9X GEMIN5 TACC2 RAB11FIP1 BRD8 MKI67 AKAP13 RPRD2 TACC3 EIF4G3 TP53BP1 | 8.60e-06 | 503 | 172 | 12 | 16964243 | |
| Pubmed | 9.77e-06 | 9 | 172 | 3 | 28705869 | ||
| Pubmed | 1.03e-05 | 209 | 172 | 8 | 36779422 | ||
| Pubmed | DMTF1 HHEX ZSCAN12 PHF20 LCORL FOSL2 ASH1L ATF6B TFAP4 BRD8 BBX KLF9 ELK1 DMRT1 ZNF292 | 1.30e-05 | 808 | 172 | 15 | 20412781 | |
| Pubmed | 1.39e-05 | 10 | 172 | 3 | 12970426 | ||
| Pubmed | Oncogene EVI1 drives acute myeloid leukemia via a targetable interaction with CTBP2. | 2.43e-05 | 2 | 172 | 2 | 38748792 | |
| Pubmed | Structure of a force-conveying cadherin bond essential for inner-ear mechanotransduction. | 2.43e-05 | 2 | 172 | 2 | 23135401 | |
| Pubmed | Using thermal scanning assays to test protein-protein interactions of inner-ear cadherins. | 2.43e-05 | 2 | 172 | 2 | 29261728 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 11847113 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 19270079 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 37060810 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 21940737 | ||
| Pubmed | EDA2R-NIK signalling promotes muscle atrophy linked to cancer cachexia. | 2.43e-05 | 2 | 172 | 2 | 37165186 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 15537665 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 16573167 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 32835555 | ||
| Pubmed | Double homozygous waltzer and Ames waltzer mice provide no evidence of retinal degeneration. | 2.43e-05 | 2 | 172 | 2 | 19057657 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 21111564 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 32579474 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 21532990 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 9060628 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 29460892 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 2.43e-05 | 2 | 172 | 2 | 9460924 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 30913874 | ||
| Pubmed | Microtubule-associated protein 1B: a neuronal binding partner for myelin-associated glycoprotein. | 2.43e-05 | 2 | 172 | 2 | 11733546 | |
| Pubmed | Nodal flow transfers polycystin to determine mouse left-right asymmetry. | 2.43e-05 | 2 | 172 | 2 | 37413993 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 20739546 | ||
| Pubmed | Lin28b reprograms adult bone marrow hematopoietic progenitors to mediate fetal-like lymphopoiesis. | 2.43e-05 | 2 | 172 | 2 | 22345399 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 23451239 | ||
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 2.43e-05 | 2 | 172 | 2 | 11672541 | |
| Pubmed | TACC3 expression is tightly regulated during early differentiation. | 2.43e-05 | 2 | 172 | 2 | 12711550 | |
| Pubmed | DNA Damage Regulates Translation through β-TRCP Targeting of CReP. | 2.68e-05 | 35 | 172 | 4 | 26091241 | |
| Pubmed | SFSWAP MAP1B TCOF1 LARP4 FSIP2 MKI67 CTBP2 RPRD2 TACC3 TP53BP1 | 3.25e-05 | 399 | 172 | 10 | 35987950 | |
| Pubmed | Desmoglein 2 regulates cardiogenesis by restricting hematopoiesis in the developing murine heart. | 3.28e-05 | 13 | 172 | 3 | 34737300 | |
| Pubmed | ZFAT LIN28B LAMTOR5 USP9X MECOM IRF2 TSC1 TFAP4 MSL2 ACSL1 NOP58 BRD8 KMT5B KLF9 ZBTB40 HELZ ELK1 SLC23A1 ZNF292 | 3.42e-05 | 1327 | 172 | 19 | 32694731 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | TCOF1 USP9X MECOM TSC1 TACC2 CEP192 YEATS2 ATF7IP HELZ CTBP2 GAB1 TP53BP1 | 3.98e-05 | 588 | 172 | 12 | 38580884 |
| Pubmed | BOC DENND4A ZBTB38 ZFAT RASGRF2 LAMTOR5 WWP1 AKAP12 XIRP2 ZBTB40 ARHGAP21 | 4.07e-05 | 497 | 172 | 11 | 23414517 | |
| Pubmed | 4.16e-05 | 14 | 172 | 3 | 28981838 | ||
| Pubmed | DENND4A MOSPD2 ZFYVE16 FNDC3A TSC1 ATF6B AKAP12 ITPR2 INF2 PPP1R15B ATP4A | 4.61e-05 | 504 | 172 | 11 | 34432599 | |
| Pubmed | 6.19e-05 | 136 | 172 | 6 | 25429064 | ||
| Pubmed | 6.65e-05 | 85 | 172 | 5 | 15449545 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 30782931 | ||
| Pubmed | Evi-1 transforming and repressor activities are mediated by CtBP co-repressor proteins. | 7.27e-05 | 3 | 172 | 2 | 11328817 | |
| Pubmed | The TACC domain identifies a family of centrosomal proteins that can interact with microtubules. | 7.27e-05 | 3 | 172 | 2 | 11121038 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 23798419 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 15226440 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 25675513 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 9971820 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 22084117 | ||
| Pubmed | PIP5KI gamma is required for cardiovascular and neuronal development. | 7.27e-05 | 3 | 172 | 2 | 17609388 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 11751946 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 7533044 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 23494474 | ||
| Pubmed | Fibromodulin modulates myoblast differentiation by controlling calcium channel. | 7.27e-05 | 3 | 172 | 2 | 29913145 | |
| Pubmed | Mapping quantitative trait loci for hearing loss in Black Swiss mice. | 7.27e-05 | 3 | 172 | 2 | 16426780 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 11783017 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 30171204 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 16679490 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 9021139 | ||
| Pubmed | Characterization of CD44+ALDH1+Ki-67- Cells in Non-malignant and Neoplastic Lesions of the Breast. | 7.27e-05 | 3 | 172 | 2 | 27630305 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 15928608 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 12479099 | ||
| Pubmed | HBXIP up-regulates ACSL1 through activating transcriptional factor Sp1 in breast cancer. | 7.27e-05 | 3 | 172 | 2 | 28132807 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 20498078 | ||
| Pubmed | Expression of E- and N-cadherin and CD44 in endometrium and hydrosalpinges from infertile women. | 7.27e-05 | 3 | 172 | 2 | 20605145 | |
| Pubmed | Cadherin 23 and protocadherin 15 interact to form tip-link filaments in sensory hair cells. | 7.27e-05 | 3 | 172 | 2 | 17805295 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 7530740 | ||
| Pubmed | Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma. | 7.27e-05 | 3 | 172 | 2 | 28945172 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 8.43e-05 | 361 | 172 | 9 | 26167880 | |
| Pubmed | A germline-specific class of small RNAs binds mammalian Piwi proteins. | SPATA31E1 PHF20 ASH1L AKAP12 FSIP2 YEATS2 NOP58 AFAP1 KNDC1 ARHGAP20 | 8.85e-05 | 450 | 172 | 10 | 16751776 |
| Pubmed | ZSCAN12 TCOF1 USP9X MPDZ TSC1 TMEM132B ATF6B AKAP12 ATF7IP CTBP2 TACC3 RAPGEF2 CDH2 ARHGAP21 TP53BP1 | 9.53e-05 | 963 | 172 | 15 | 28671696 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 8.93e-04 | 34 | 101 | 3 | 487 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.05e-03 | 206 | 101 | 6 | 682 | |
| GeneFamily | UPF1 like RNA helicases | 1.64e-03 | 11 | 101 | 2 | 1169 | |
| GeneFamily | Fibronectin type III domain containing | 2.04e-03 | 160 | 101 | 5 | 555 | |
| GeneFamily | ATP binding cassette subfamily A | 2.69e-03 | 14 | 101 | 2 | 805 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | COL5A2 TANK PHF20 MAP1B ZFYVE16 USP9X WWP1 MAP3K14 MECOM FNDC3A LARP4 ZNF804A TRAK1 AFAP1 BBX ARHGEF10 HELZ AKAP13 CTBP2 RAPGEF2 EIF4G3 CDH2 AQR TP53BP1 IL7R ZNF292 | 1.97e-11 | 856 | 162 | 26 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | COL5A2 MAP1B USP9X FNDC3A LARP4 ZNF804A TRAK1 AFAP1 BBX HELZ CTBP2 RAPGEF2 EIF4G3 IL7R ZNF292 | 2.24e-07 | 466 | 162 | 15 | M13522 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | DMTF1 FNDC3A ICE1 BRD8 BBX MAST4 KLF9 MKI67 HELZ CTBP2 RAPGEF2 | 2.84e-06 | 300 | 162 | 11 | M8702 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | DMTF1 RALGDS TANK SFSWAP PSG7 FOSL2 MAP3K14 UBAP1 TSC1 ZNF395 RAB11FIP1 LARP4 FBXO38 PLEKHO2 KLF9 ATF7IP ZBTB40 DNAJB2 | 3.61e-06 | 822 | 162 | 18 | M6782 |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 4.05e-06 | 68 | 162 | 6 | M1373 | |
| Coexpression | GSE11057_CD4_CENT_MEM_VS_PBMC_UP | PHACTR2 RASGRF2 WWP1 PIEZO1 MAP3K14 ASH1L PIK3IP1 PCNX2 MAST4 | 4.17e-06 | 198 | 162 | 9 | M3116 |
| Coexpression | GSE22589_HEALTHY_VS_SIV_INFECTED_DC_DN | ZBTB38 RAB11FIP1 ZNF804A AKAP12 ITPR2 ACSL1 SIGLEC1 NOS2 IL7R | 4.34e-06 | 199 | 162 | 9 | M7809 |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_UP | 4.53e-06 | 200 | 162 | 9 | M9838 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP | DMTF1 RASGRF2 ASH1L ARHGEF10 C3orf70 RPRD2 RAPGEF2 ARHGAP20 ZNF292 | 4.53e-06 | 200 | 162 | 9 | M7430 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | DMTF1 GPR155 RALGDS DENND4A ZBTB38 TANK PHF20 USP9X PIEZO1 ASH1L ICE1 RFX7 EPG5 ITPR2 PIK3IP1 PCNX2 BBX PLEKHO2 ATF7IP PPP1R15B CD44 HELZ AKAP13 IL7R ZNF292 | 5.24e-06 | 1492 | 162 | 25 | M40023 |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 5.67e-06 | 72 | 162 | 6 | MM1131 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | ZSCAN12 MOSPD2 TCOF1 RBL1 FOSL2 MDFI ERI2 TFAP4 AKAP12 NOP58 BRD8 ARHGEF10 KMT5B CD44 ELK1 ZNF292 | 2.69e-05 | 776 | 162 | 16 | M1107 |
| Coexpression | GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP | 3.37e-05 | 198 | 162 | 8 | M8036 | |
| Coexpression | GSE23695_CD57_POS_VS_NEG_NK_CELL_UP | 3.49e-05 | 199 | 162 | 8 | M7784 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP | 3.49e-05 | 199 | 162 | 8 | M5254 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | ZSCAN12 MOSPD2 TCOF1 RBL1 FOSL2 MDFI ERI2 TFAP4 AKAP12 NOP58 BRD8 ARHGEF10 KMT5B CD44 ELK1 ZNF292 | 3.54e-05 | 794 | 162 | 16 | MM982 |
| Coexpression | AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53 | 5.49e-05 | 107 | 162 | 6 | M8268 | |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_DN | 5.90e-05 | 158 | 162 | 7 | M372 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | PHACTR2 MAP3K14 MECOM TUFT1 PIK3IP1 FBXO38 PLA2R1 PPP1R15B RAPGEF2 DNAJB2 CDH2 GAB1 | 7.44e-05 | 504 | 162 | 12 | M2157 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 1.16e-04 | 176 | 162 | 7 | M39223 | |
| Coexpression | ALFANO_MYC_TARGETS | 1.26e-04 | 239 | 162 | 8 | M2477 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 1.29e-04 | 240 | 162 | 8 | M39236 | |
| Coexpression | WIERENGA_STAT5A_TARGETS_GROUP1 | 1.42e-04 | 127 | 162 | 6 | M2215 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | PHACTR2 SFSWAP BAG4 ZNF395 RFX7 ATF6B EPG5 CCDC66 BBX KLF9 CD44 | 1.86e-04 | 474 | 162 | 11 | M40991 |
| Coexpression | MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6 | 2.04e-04 | 47 | 162 | 4 | M1652 | |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN | 2.12e-04 | 194 | 162 | 7 | M7306 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP | 2.19e-04 | 195 | 162 | 7 | M4201 | |
| Coexpression | GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP | 2.40e-04 | 198 | 162 | 7 | M3200 | |
| Coexpression | GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_DN | 2.40e-04 | 198 | 162 | 7 | M7229 | |
| Coexpression | GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_DN | 2.40e-04 | 198 | 162 | 7 | M7916 | |
| Coexpression | GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_UP | 2.47e-04 | 199 | 162 | 7 | M324 | |
| Coexpression | GSE2128_C57BL6_VS_NOD_THYMOCYTE_MIMETOPE_NEGATIVE_SELECTION_DN | 2.47e-04 | 199 | 162 | 7 | M6182 | |
| Coexpression | GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 2.47e-04 | 199 | 162 | 7 | M5357 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 2.47e-04 | 199 | 162 | 7 | M9180 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN | 2.55e-04 | 200 | 162 | 7 | M9463 | |
| Coexpression | GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_UP | 2.55e-04 | 200 | 162 | 7 | M8038 | |
| Coexpression | GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_UP | 2.55e-04 | 200 | 162 | 7 | M8085 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_DN | 2.55e-04 | 200 | 162 | 7 | M9327 | |
| Coexpression | GSE17721_0.5H_VS_4H_CPG_BMDC_DN | 2.55e-04 | 200 | 162 | 7 | M4125 | |
| Coexpression | WIERENGA_STAT5A_TARGETS_UP | 2.71e-04 | 202 | 162 | 7 | M2210 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | JCAD HHEX ZBTB38 MOSPD2 PHF20 ZFYVE16 USP9X MTSS1 ASH1L FNDC3A ZNF518A BBX MAST4 INF2 RAPGEF2 | 2.81e-04 | 854 | 162 | 15 | M1533 |
| Coexpression | MANALO_HYPOXIA_UP | 2.96e-04 | 205 | 162 | 7 | M259 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PHACTR2 MAP1B KIF26A MECOM MDFI TFAP4 AKAP12 PLA2R1 MAST4 ARHGEF10 PLXNA4 ZBTB40 MAML3 | 1.35e-13 | 179 | 163 | 13 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-08 | 191 | 163 | 9 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-08 | 191 | 163 | 9 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.41e-07 | 186 | 163 | 8 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.41e-07 | 186 | 163 | 8 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.98e-07 | 189 | 163 | 8 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.18e-07 | 190 | 163 | 8 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-07 | 191 | 163 | 8 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.61e-07 | 192 | 163 | 8 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.07e-07 | 194 | 163 | 8 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.31e-07 | 195 | 163 | 8 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | (5)_Fibroblast-D|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.35e-07 | 199 | 163 | 8 | 3f415620ad8b8d8c6871e1353e13f87b281fcc0e | |
| ToppCell | Transverse-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 7.35e-07 | 199 | 163 | 8 | 170ae68963d31f3b821b6f0e8f0c039bea0bc981 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-06 | 152 | 163 | 7 | b8aa62e3cf2b4c252db4bccfa75d881c4fa0a788 | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like-ILC3|Liver / Manually curated celltypes from each tissue | 2.39e-06 | 163 | 163 | 7 | 7f61483eeb1fde21843c6391468e13cb0cc2a89f | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.69e-06 | 166 | 163 | 7 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-06 | 167 | 163 | 7 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | (7)_MNP-(7)_DC_activated|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.15e-06 | 170 | 163 | 7 | 4ab495b38a071fa8207331df2ce0d78a2dcd034e | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.27e-06 | 178 | 163 | 7 | a493a277d175e5e153410a745b26ebe2e0839ea0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.27e-06 | 178 | 163 | 7 | 371218babddfd3d8a7bb82a46ce65327ee3fcf12 | |
| ToppCell | Somatosensory_Cortex_(S1)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.43e-06 | 179 | 163 | 7 | 82348bf56a4525b2f485696cab5b2ea6e96c2f91 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.12e-06 | 183 | 163 | 7 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.31e-06 | 184 | 163 | 7 | 8bcb1c4bc8ffef74338cdade926a94711de93c64 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.31e-06 | 184 | 163 | 7 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.50e-06 | 185 | 163 | 7 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-06 | 185 | 163 | 7 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.90e-06 | 187 | 163 | 7 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 6.11e-06 | 188 | 163 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-Treg|COVID-19_Mild / Disease group, lineage and cell class | 6.11e-06 | 188 | 163 | 7 | 42553fdc127e5f613ffd5067620a768a40f1a8a1 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 6.33e-06 | 189 | 163 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 6.33e-06 | 189 | 163 | 7 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 6.55e-06 | 190 | 163 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | CV-Moderate-0|Moderate / Virus stimulation, Condition and Cluster | 6.78e-06 | 191 | 163 | 7 | 6776bcc4c1915f0c1062002ff7746f20ceb725f4 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 7.02e-06 | 192 | 163 | 7 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-06 | 192 | 163 | 7 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.26e-06 | 193 | 163 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.26e-06 | 193 | 163 | 7 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.26e-06 | 193 | 163 | 7 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.51e-06 | 194 | 163 | 7 | 8f4b63b0b9a40765205e4ca6bd94a675a83dbe3d | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.51e-06 | 194 | 163 | 7 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.51e-06 | 194 | 163 | 7 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.76e-06 | 195 | 163 | 7 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.76e-06 | 195 | 163 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.76e-06 | 195 | 163 | 7 | 4dba732c8d8ecf0ed9ece1814dc4060402199ed9 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.76e-06 | 195 | 163 | 7 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 8.03e-06 | 196 | 163 | 7 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.30e-06 | 197 | 163 | 7 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD4+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 8.30e-06 | 197 | 163 | 7 | c842d169dfce9af3ed7c01dc7e940c0bdd21388c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.30e-06 | 197 | 163 | 7 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | T_cells-Treg_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 8.30e-06 | 197 | 163 | 7 | ec9398ae3577f61d6b1e6aba50ef4261aaaa7610 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.30e-06 | 197 | 163 | 7 | b2f4d7c301c0b24003374923b31d6d058e40b213 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-06 | 197 | 163 | 7 | cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40 | |
| ToppCell | T_cells-Treg_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 8.30e-06 | 197 | 163 | 7 | de5448fcdf4e433fc167496413abe5d0c8a5c6d8 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-CD8+_T_naive|URO / Disease, condition lineage and cell class | 8.57e-06 | 198 | 163 | 7 | c07426d4119b53e58eb5f448ae364f47cac1fc5c | |
| ToppCell | medial|World / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.57e-06 | 198 | 163 | 7 | 071658de0c43f302172692aa0b4b507dbad7be50 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 8.57e-06 | 198 | 163 | 7 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.86e-06 | 199 | 163 | 7 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 8.86e-06 | 199 | 163 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.86e-06 | 199 | 163 | 7 | 9846d6a31635fde759d55674631c11ab9270a603 | |
| ToppCell | Transverse-(2)_B_cell-(24)_B_cell_cycling|Transverse / shred on region, Cell_type, and subtype | 9.15e-06 | 200 | 163 | 7 | e3f9736227151f23f0e331eec0a7a15ce464b517 | |
| ToppCell | Transverse-B_cell-B_cell_cycling|Transverse / Region, Cell class and subclass | 9.15e-06 | 200 | 163 | 7 | 0e270f8019d9f22068ca426d661937262a5cd331 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-Treg|COVID-19_Mild / Disease, condition lineage and cell class | 9.15e-06 | 200 | 163 | 7 | c6ae15f7deba26008af5b647855675003bb2ebcd | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.15e-06 | 200 | 163 | 7 | 24e13b6d9d2d8b29df1f02544ea9c50084d9e75c | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.15e-06 | 200 | 163 | 7 | 8d2ceb2080c67b20f452eeca605aa27a58033c04 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-2,_SCARA5|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 9.15e-06 | 200 | 163 | 7 | c338a08c1605527ab9aaf62ea151a19e8469dc6d | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.15e-06 | 200 | 163 | 7 | 0b2614b8513693dd508c9003699049efd9abac52 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.15e-06 | 200 | 163 | 7 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Severe-B_naive-9|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.24e-05 | 139 | 163 | 6 | b9b049953958f15d773eb5cca6d5dc34f4829543 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Astrocyte|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.40e-05 | 142 | 163 | 6 | 85e573616e54d41391b4ad8c3d38e4ca92112673 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-05 | 146 | 163 | 6 | 1bf67a9416f52198931b912a31be4bab09fefd19 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.14e-05 | 153 | 163 | 6 | 5424494ea1f09542799045a875cc3eac13de5079 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.31e-05 | 155 | 163 | 6 | 335cd798afbaa0a3a3e1dc558a81cfa32da48983 | |
| ToppCell | Healthy_donor-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 2.86e-05 | 161 | 163 | 6 | 8a61395af33132783a0a37956c6f821aba5d3b1e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.06e-05 | 163 | 163 | 6 | a6e272e043859858084b8d4d96fa4ff9e6eca454 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.06e-05 | 163 | 163 | 6 | 1e8730d75cccf7292010683ab4e81a69d8e3bfa9 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.28e-05 | 165 | 163 | 6 | a379fa981db51bec01adea7b1e55e133e15ec383 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 3.75e-05 | 169 | 163 | 6 | 241644823e6f949aaf4c671d4579721d7ef6b0e5 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.87e-05 | 170 | 163 | 6 | df1a34a69ae404c56f00751a01f52359535f5469 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.00e-05 | 171 | 163 | 6 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | Control-Myeloid-Mast|World / Disease state, Lineage and Cell class | 4.00e-05 | 171 | 163 | 6 | ed8e61d524f4cddc6084b261175df54d2a64a60f | |
| ToppCell | Ciliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 4.13e-05 | 172 | 163 | 6 | 187ae91148d293537afc77e10da2b64302322224 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-05 | 172 | 163 | 6 | 1627fa7035b0e0bbc82a1c0f000d8231254c680a | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.13e-05 | 172 | 163 | 6 | 028a5441242b2cc760cafc1822120180619c63ae | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.13e-05 | 172 | 163 | 6 | 9fc70b1a143a8ec910336c23b761d908bb6aecb2 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-05 | 172 | 163 | 6 | 574ebdf36e45222bcd907cd2c2ee7ff50ed4573a | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.13e-05 | 172 | 163 | 6 | 13d7117f92a92d77d6b4335ed800c585dc8b4511 | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.13e-05 | 172 | 163 | 6 | 3d83b2f03ad3af4dae3fe6cc0a0ef356872ca94f | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.13e-05 | 172 | 163 | 6 | a3d431aed12c1192e8dca1dc85b8340fb7354f8d | |
| ToppCell | facs-Trachea-nan-24m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-05 | 173 | 163 | 6 | 27ae126c720f20d1fe116abbcd358e4cff8baf6b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.27e-05 | 173 | 163 | 6 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.27e-05 | 173 | 163 | 6 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | Healthy_donor-Treg|World / disease group, cell group and cell class (v2) | 4.41e-05 | 174 | 163 | 6 | dc3b06420b0ad9c7060571e7bf5714e028d598bf | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.41e-05 | 174 | 163 | 6 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.41e-05 | 174 | 163 | 6 | f1510b0f7771936adf29ae3572feab55db31832b | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.41e-05 | 174 | 163 | 6 | 5d5d2fc60afff47f997751e8e9ca1367a22d19ec | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-05 | 176 | 163 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.70e-05 | 176 | 163 | 6 | 40993c41c1017b53039a337174fc56632b278609 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.85e-05 | 177 | 163 | 6 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-CD45____plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 177 | 163 | 6 | 41cbb2c109eaa7be366fc0510cce64abc06837b4 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-05 | 178 | 163 | 6 | 0b456ac768e026c3ecd5a9a4f43d6f126e7685a1 | |
| Drug | Repaglinide [135062-02-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | MAP1B RBL1 INF2 ZBTB40 AKAP13 ELK1 RAPGEF2 PLCH1 DNAAF1 ZNF292 | 1.62e-06 | 198 | 162 | 10 | 7216_DN |
| Drug | Chenodiol [474-25-9]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.62e-06 | 198 | 162 | 10 | 7433_UP | |
| Drug | Ticarcillin sodium [4697-14-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A | RALGDS HHEX DENND4A TANK RBL1 MECOM FNDC3A FAM131A CD44 RAPGEF2 | 1.70e-06 | 199 | 162 | 10 | 7185_UP |
| Drug | Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A | MAP1B FAM131A PIK3IP1 AFAP1 KLF9 CD44 ZBTB40 AKAP13 RAPGEF2 DNAAF1 | 1.77e-06 | 200 | 162 | 10 | 4824_DN |
| Drug | Praziquantel [55268-74-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.18e-05 | 196 | 162 | 9 | 7228_DN | |
| Drug | Terazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.18e-05 | 196 | 162 | 9 | 7187_DN | |
| Drug | Leflunomide [75706-12-6]; Down 200; 14.8uM; PC3; HT_HG-U133A | 1.22e-05 | 197 | 162 | 9 | 5884_DN | |
| Drug | Sisomicin sulfate [53179-09-2]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.22e-05 | 197 | 162 | 9 | 2853_DN | |
| Drug | Antipyrine [60-80-0]; Up 200; 21.2uM; MCF7; HT_HG-U133A | 1.27e-05 | 198 | 162 | 9 | 1489_UP | |
| Drug | Norethynodrel [68-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.33e-05 | 199 | 162 | 9 | 7471_DN | |
| Drug | norbornadiene | 1.97e-05 | 23 | 162 | 4 | CID000008473 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 3.18e-05 | 171 | 162 | 8 | 7535_DN | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 5.35e-05 | 184 | 162 | 8 | 1007_UP | |
| Drug | Pyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; MCF7; HT_HG-U133A | 5.56e-05 | 185 | 162 | 8 | 5439_DN | |
| Drug | Magnetite Nanoparticles | GPR155 PALD1 MOSPD2 TANK ZFYVE16 RBL1 USP9X WWP1 FOSL2 MTSS1 ASH1L MECOM RFX7 ZNF804A ZNF518A ITPR2 BRD8 CD44 MKI67 HELZ PAPPA NOS2 ZNF292 | 5.59e-05 | 1310 | 162 | 23 | ctd:D058185 |
| Drug | prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HT_HG-U133A | 6.00e-05 | 187 | 162 | 8 | 6975_UP | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 6.23e-05 | 188 | 162 | 8 | 6735_DN | |
| Drug | Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 6.71e-05 | 190 | 162 | 8 | 3833_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; ssMCF7; HG-U133A | 6.96e-05 | 191 | 162 | 8 | 497_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A | 6.96e-05 | 191 | 162 | 8 | 1665_UP | |
| Drug | Syrosingopine [84-36-6]; Up 200; 6uM; MCF7; HT_HG-U133A | 7.22e-05 | 192 | 162 | 8 | 6213_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A | 7.22e-05 | 192 | 162 | 8 | 1634_UP | |
| Drug | 0316684-0000 [391209-55-5]; Down 200; 10uM; PC3; HT_HG-U133A | 7.76e-05 | 194 | 162 | 8 | 7098_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A | 8.04e-05 | 195 | 162 | 8 | 6999_UP | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 8.33e-05 | 196 | 162 | 8 | 5680_DN | |
| Drug | Bacitracin [1405-87-4]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 8.33e-05 | 196 | 162 | 8 | 7448_DN | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 8.33e-05 | 196 | 162 | 8 | 2225_DN | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 8.64e-05 | 197 | 162 | 8 | 2259_DN | |
| Drug | Spaglumic acid [4910-46-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 8.64e-05 | 197 | 162 | 8 | 7465_DN | |
| Drug | Chloropyramine hydrochloride [6170-42-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 8.64e-05 | 197 | 162 | 8 | 3350_UP | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; PC3; HT_HG-U133A | 8.64e-05 | 197 | 162 | 8 | 7293_DN | |
| Drug | 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol | 8.80e-05 | 314 | 162 | 10 | ctd:C572491 | |
| Drug | Chlorzoxazone [95-25-0]; Down 200; 23.6uM; MCF7; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 7456_DN | |
| Drug | Vigabatrin [60643-86-9]; Down 200; 31uM; PC3; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 6314_DN | |
| Drug | Gelsemine [509-15-9]; Down 200; 12.4uM; HL60; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 2162_DN | |
| Drug | Rifampicin [13292-46-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 2847_DN | |
| Drug | Epivincamine [6835-99-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 6838_DN | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; MCF7; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 6239_DN | |
| Drug | (R)-(+)-Atenolol [56715-13-0]; Down 200; 15uM; MCF7; HT_HG-U133A | 9.26e-05 | 199 | 162 | 8 | 2855_DN | |
| Drug | Delsoline [509-18-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 9.26e-05 | 199 | 162 | 8 | 6075_DN | |
| Drug | monastrol; Down 200; 100uM; PC3; HG-U133A | 9.26e-05 | 199 | 162 | 8 | 668_DN | |
| Drug | Succimer | GPR155 PALD1 MOSPD2 TANK ZFYVE16 RBL1 USP9X WWP1 FOSL2 MTSS1 ASH1L MECOM RFX7 ZNF804A ZNF518A ITPR2 BRD8 CD44 MKI67 HELZ PAPPA ZNF292 | 9.35e-05 | 1264 | 162 | 22 | ctd:D004113 |
| Drug | Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 9.59e-05 | 200 | 162 | 8 | 3477_DN | |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 2.72e-05 | 216 | 162 | 8 | EFO_0007925, EFO_0007927 | |
| Disease | Usher syndrome, type 1D | 3.00e-05 | 2 | 162 | 2 | C2931208 | |
| Disease | USHER SYNDROME, TYPE ID | 3.00e-05 | 2 | 162 | 2 | C1832845 | |
| Disease | USHER SYNDROME, TYPE ID | 3.00e-05 | 2 | 162 | 2 | 601067 | |
| Disease | Usher syndrome type 1D | 3.00e-05 | 2 | 162 | 2 | cv:C1832845 | |
| Disease | Usher syndrome type 1D (is_implicated_in) | 3.00e-05 | 2 | 162 | 2 | DOID:0110831 (is_implicated_in) | |
| Disease | forced expiratory volume | BOC JCAD ZBTB38 ZFAT LCORL LIN28B PIEZO1 PKDCC MECOM PLEKHO2 PCDH15 PLXNA4 ZBTB40 RPRD2 GAB1 | 3.21e-05 | 789 | 162 | 15 | EFO_0004314 |
| Disease | Malignant neoplasm of breast | BOC HHEX TANK RASGRF2 LAMTOR5 MECOM FAM131A TACC2 AKAP12 WDR53 EPG5 MKI67 DLEC1 CDH2 NOS2 GAB1 TP53BP1 | 9.23e-05 | 1074 | 162 | 17 | C0006142 |
| Disease | Colorectal Carcinoma | BOC RALGDS MAP1B RASGRF2 TCOF1 ABCA13 ERI2 ZNF804A ABCA10 AKAP12 MKI67 NODAL ZNF292 | 1.42e-04 | 702 | 162 | 13 | C0009402 |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | JCAD TANK RASGRF2 KIF26A CDH23 TACC2 TMEM132B ZNF518A KCNU1 BARHL2 PCDH15 PLXNA4 HELZ MAML3 | 1.43e-04 | 801 | 162 | 14 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | household income | 2.90e-04 | 304 | 162 | 8 | EFO_0009695 | |
| Disease | Usher syndrome, type 1A | 2.96e-04 | 5 | 162 | 2 | C2931205 | |
| Disease | mucositis (biomarker_via_orthology) | 2.96e-04 | 5 | 162 | 2 | DOID:0080178 (biomarker_via_orthology) | |
| Disease | USHER SYNDROME, TYPE IB (disorder) | 2.96e-04 | 5 | 162 | 2 | C1848638 | |
| Disease | USHER SYNDROME, TYPE IA, FORMERLY | 2.96e-04 | 5 | 162 | 2 | C1848639 | |
| Disease | USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY | 2.96e-04 | 5 | 162 | 2 | C1848640 | |
| Disease | Usher syndrome type 1 | 2.96e-04 | 5 | 162 | 2 | cv:C1568247 | |
| Disease | cognitive function measurement | DENND4A TNFAIP8L3 LCORL PIEZO1 MTSS1 MAP3K14 ENTHD1 CEP192 ZNF804A CCDC66 BBX MAST4 ARHGEF10 ATF7IP BARHL2 PLXNA4 CDH2 MAML3 ARHGAP21 | 3.48e-04 | 1434 | 162 | 19 | EFO_0008354 |
| Disease | Ciliopathies | 3.61e-04 | 110 | 162 | 5 | C4277690 | |
| Disease | ovarian carcinoma | 4.17e-04 | 321 | 162 | 8 | EFO_0001075 | |
| Disease | Tumor of Rete Testis | 4.43e-04 | 6 | 162 | 2 | C1720811 | |
| Disease | Usher Syndrome, Type I | 4.43e-04 | 6 | 162 | 2 | C1568247 | |
| Disease | Hereditary retinal dystrophy | 6.18e-04 | 7 | 162 | 2 | C0154860 | |
| Disease | Malignant neoplasm of testis | 6.18e-04 | 7 | 162 | 2 | C0153594 | |
| Disease | Usher syndrome | 6.18e-04 | 7 | 162 | 2 | cv:C0271097 | |
| Disease | smoking behavior | 6.20e-04 | 341 | 162 | 8 | EFO_0004318 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 6.82e-04 | 346 | 162 | 8 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | femoral neck bone mineral density | 7.72e-04 | 196 | 162 | 6 | EFO_0007785 | |
| Disease | Testicular Neoplasms | 8.21e-04 | 8 | 162 | 2 | C0039590 | |
| Disease | neuroimaging measurement | COL5A2 MAP1B LCORL PKDCC TACC2 LARP4 TFAP4 AFAP1 MAST4 PAPPA CTBP2 TACC3 RAPGEF2 PLCH1 DMRT1 | 8.44e-04 | 1069 | 162 | 15 | EFO_0004346 |
| Disease | coronary artery disease | JCAD MAP1B CCDC30 LCORL MECOM AKAP12 EPG5 MSL2 MAST4 LPA AKAP13 RPRD2 DLEC1 RAPGEF2 ARHGAP20 ARHGAP21 | 9.22e-04 | 1194 | 162 | 16 | EFO_0001645 |
| Disease | Situs ambiguous | 1.05e-03 | 9 | 162 | 2 | C1167664 | |
| Disease | lymphocyte percentage of leukocytes | PALD1 CACNA1S ZBTB38 MOSPD2 RBL1 CDH23 RFX7 MSL2 HELZ IL7R ZNF292 | 1.17e-03 | 665 | 162 | 11 | EFO_0007993 |
| Disease | lean body mass | 1.22e-03 | 379 | 162 | 8 | EFO_0004995 | |
| Disease | Abnormality of refraction | JCAD ZBTB38 LCORL PKD1L1 ITPR2 CCDC66 BARHL2 AKAP13 CTBP2 DLEC1 CDH2 | 1.28e-03 | 673 | 162 | 11 | HP_0000539 |
| Disease | chronic obstructive pulmonary disease | BOC JCAD ZBTB38 ZSCAN12 PIEZO1 MECOM ATF6B FBXO38 AFAP1 DLEC1 MAML3 | 1.53e-03 | 688 | 162 | 11 | EFO_0000341 |
| Disease | gastric adenocarcinoma (is_implicated_in) | 1.59e-03 | 11 | 162 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | Situs Inversus | 1.59e-03 | 11 | 162 | 2 | C0037221 | |
| Disease | visceral heterotaxy (is_implicated_in) | 1.91e-03 | 12 | 162 | 2 | DOID:0050545 (is_implicated_in) | |
| Disease | lifestyle measurement | 1.95e-03 | 235 | 162 | 6 | EFO_0010724 | |
| Disease | selective IgA deficiency disease | 2.07e-03 | 46 | 162 | 3 | EFO_1001929 | |
| Disease | refractive error | 2.23e-03 | 326 | 162 | 7 | MONDO_0004892 | |
| Disease | Respiratory Depression | 2.25e-03 | 13 | 162 | 2 | C0235063 | |
| Disease | Respiratory Insufficiency | 2.25e-03 | 13 | 162 | 2 | C0035229 | |
| Disease | Respiratory Failure | 2.25e-03 | 13 | 162 | 2 | C1145670 | |
| Disease | Alzheimer's disease biomarker measurement | 2.34e-03 | 48 | 162 | 3 | EFO_0006514 | |
| Disease | pancreatic cancer (is_marker_for) | 2.36e-03 | 101 | 162 | 4 | DOID:1793 (is_marker_for) | |
| Disease | platelet crit | JCAD KIF26A PIEZO1 MAP3K14 MECOM EPG5 ITPR2 PLA2R1 BBX MAST4 PLEKHO2 LPA RPRD2 | 2.37e-03 | 952 | 162 | 13 | EFO_0007985 |
| Disease | susceptibility to measles measurement | 2.49e-03 | 49 | 162 | 3 | EFO_0008414 | |
| Disease | Mammary Carcinoma, Human | 2.56e-03 | 525 | 162 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.56e-03 | 525 | 162 | 9 | C1257931 | |
| Disease | superior frontal gyrus grey matter volume measurement | 2.61e-03 | 14 | 162 | 2 | EFO_0006516 | |
| Disease | Mammary Neoplasms | 2.63e-03 | 527 | 162 | 9 | C1458155 | |
| Disease | C-reactive protein measurement | LCORL FOSL2 CEP192 MSL2 YEATS2 NOP58 LPA PCDH15 ZBTB40 EIF4G3 MAML3 IL4R ARHGAP21 TP53BP1 IL7R | 2.73e-03 | 1206 | 162 | 15 | EFO_0004458 |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 2.79e-03 | 51 | 162 | 3 | cv:CN043650 | |
| Disease | QT interval | 2.87e-03 | 534 | 162 | 9 | EFO_0004682 | |
| Disease | lymphocyte count | PALD1 JCAD CACNA1S ZBTB38 ZFAT LCORL RBL1 PIEZO1 CDH23 ZNF395 RFX7 ITPR2 CCDC66 HELZ PAPPA SIGLEC1 IL7R | 2.93e-03 | 1464 | 162 | 17 | EFO_0004587 |
| Disease | Germ Cell Cancer | 3.00e-03 | 15 | 162 | 2 | C0740345 | |
| Disease | Situs ambiguus | 3.00e-03 | 15 | 162 | 2 | C0266642 | |
| Disease | Embryonal Neoplasm | 3.00e-03 | 15 | 162 | 2 | C0027654 | |
| Disease | Neoplasms, Germ Cell and Embryonal | 3.00e-03 | 15 | 162 | 2 | C0027658 | |
| Disease | Germ cell tumor | 3.00e-03 | 15 | 162 | 2 | C0205851 | |
| Disease | Neoplasms, Embryonal and Mixed | 3.00e-03 | 15 | 162 | 2 | C0205852 | |
| Disease | posterior thigh muscle volume | 3.00e-03 | 15 | 162 | 2 | EFO_0020931 | |
| Disease | Cancer, Embryonal | 3.00e-03 | 15 | 162 | 2 | C0751364 | |
| Disease | Cancer, Embryonal and Mixed | 3.00e-03 | 15 | 162 | 2 | C0751365 | |
| Disease | Breast Carcinoma | 3.01e-03 | 538 | 162 | 9 | C0678222 | |
| Disease | obsolete_red blood cell distribution width | MAG RALGDS RBL1 PIEZO1 UBAP1 CDH23 MECOM EPG5 PIK3IP1 MAST4 MUC17 ZBTB40 AKAP13 EIF4G3 SLC23A1 ARHGAP21 | 3.12e-03 | 1347 | 162 | 16 | EFO_0005192 |
| Disease | platelet component distribution width | JCAD TANK MTSS1 MECOM BRD8 PLEKHO2 KLF9 AKAP13 DLEC1 SIGLEC1 XPO7 | 3.13e-03 | 755 | 162 | 11 | EFO_0007984 |
| Disease | waist-hip ratio | JCAD HHEX ZFAT LCORL MAP3K14 MECOM CEP192 RFX7 YEATS2 BBX MAST4 BARHL2 DLEC1 MAML3 ARHGAP21 | 3.19e-03 | 1226 | 162 | 15 | EFO_0004343 |
| Disease | mean corpuscular hemoglobin concentration | MAG DENND4A ZFAT RBL1 PIEZO1 MECOM ENTHD1 ITPR2 NOP58 AKAP13 EIF4G3 SLC23A1 ARHGAP21 XPO7 | 3.20e-03 | 1105 | 162 | 14 | EFO_0004528 |
| Disease | plasminogen activator inhibitor 1 measurement | 3.28e-03 | 54 | 162 | 3 | EFO_0004792 | |
| Disease | cortical thickness | PALD1 COL5A2 PKDCC MECOM TACC2 TFAP4 MAST4 CTBP2 DLEC1 USP35 TACC3 PLCH1 EIF4G3 ARHGAP21 | 3.41e-03 | 1113 | 162 | 14 | EFO_0004840 |
| Disease | Cardiovascular Abnormalities | 3.42e-03 | 16 | 162 | 2 | C0243050 | |
| Disease | bone fracture | 3.43e-03 | 112 | 162 | 4 | EFO_0003931 | |
| Disease | eosinophil count | HHEX ZFAT MAP3K14 ATF6B TNFRSF4 PLA2R1 PLEKHO2 ATF7IP ZBTB40 AKAP13 EIF4G3 NOS2 IL4R ALPK2 TP53BP1 IL7R ZNF292 | 3.46e-03 | 1488 | 162 | 17 | EFO_0004842 |
| Disease | brain measurement, neuroimaging measurement | 3.48e-03 | 550 | 162 | 9 | EFO_0004346, EFO_0004464 | |
| Disease | carotid artery intima media thickness | 3.53e-03 | 450 | 162 | 8 | EFO_0007117 | |
| Disease | chronotype measurement | ZFAT LCORL MDFI CBLN1 ZNF804A BARHL2 PCDH15 PLXNA4 CTBP2 RPRD2 EIF4G3 DMRT1 | 3.57e-03 | 882 | 162 | 12 | EFO_0008328 |
| Disease | corneal resistance factor | 3.58e-03 | 451 | 162 | 8 | EFO_0010067 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 3.86e-03 | 17 | 162 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | intelligence, self reported educational attainment | 4.01e-03 | 117 | 162 | 4 | EFO_0004337, EFO_0004784 | |
| Disease | Atherosclerosis | 4.22e-03 | 59 | 162 | 3 | C0004153 | |
| Disease | Atherogenesis | 4.22e-03 | 59 | 162 | 3 | C1563937 | |
| Disease | mean platelet volume | JCAD HHEX ZBTB38 PHF20 MECOM TFAP4 ACSL1 BRD8 AFAP1 BBX MAST4 PLEKHO2 KLF9 | 4.25e-03 | 1020 | 162 | 13 | EFO_0004584 |
| Disease | cholesterol to total lipids in medium HDL percentage | 4.42e-03 | 60 | 162 | 3 | EFO_0022237 | |
| Disease | balding measurement | ZBTB38 MAP3K14 PKDCC MPDZ LARP4 AKAP12 BBX ATF7IP DLEC1 TACC3 EIF4G3 | 4.47e-03 | 792 | 162 | 11 | EFO_0007825 |
| Disease | velopharyngeal dysfunction | 4.66e-03 | 122 | 162 | 4 | EFO_0009336 | |
| Disease | serum gamma-glutamyl transferase measurement | JCAD LCORL FOSL2 ASH1L ZNF804A AKAP13 SIGLEC1 ARHGAP21 ALPK2 TP53BP1 HSPB7 ZNF292 | 4.72e-03 | 914 | 162 | 12 | EFO_0004532 |
| Disease | mean reticulocyte volume | ZFAT RBL1 PIEZO1 TFAP4 FBXO38 ATF7IP ZBTB40 AKAP13 TACC3 ARHGAP21 XPO7 | 4.77e-03 | 799 | 162 | 11 | EFO_0010701 |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 4.82e-03 | 19 | 162 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | diet measurement, HOMA-B | 4.82e-03 | 19 | 162 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | Alzheimer disease, polygenic risk score | 5.24e-03 | 586 | 162 | 9 | EFO_0030082, MONDO_0004975 | |
| Disease | cholangiocarcinoma (is_marker_for) | 5.30e-03 | 64 | 162 | 3 | DOID:4947 (is_marker_for) | |
| Disease | BRCAX breast cancer | 5.33e-03 | 20 | 162 | 2 | EFO_0009443 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QSSSLPEECVPSDES | 361 | O95429 | |
| ASQPEENVDCTVPIS | 416 | A8K979 | |
| SNEESLTCNTEPPKE | 91 | Q9HCE0 | |
| SSPVIICATSLDEEA | 171 | O15013 | |
| EESSQEPQSTCTPEE | 2901 | Q9NR48 | |
| CPSAQVSPAVDSDLT | 171 | O42043 | |
| SCPSAQVSPAVDSDL | 281 | O71037 | |
| SCPSAQVSPAVDSDL | 281 | Q902F8 | |
| TEDCPPQPEVSVTST | 96 | P19419 | |
| CPSAQVSPAVDSDLT | 281 | Q9UKH3 | |
| TPEVSSGTCRPDVSE | 221 | Q8WY36 | |
| IPSAAVEETADSTIC | 126 | P56545 | |
| TAPNLEEEPVITASC | 1186 | Q8WWZ4 | |
| TTESVAPVSQPDNCV | 326 | Q9H0E9 | |
| SVEVECSSENPQLSP | 101 | Q86TB3 | |
| PTDTALTLENVCDEP | 781 | Q86TB3 | |
| SASSPEEPEEITCLE | 566 | Q02952 | |
| VKATENTVNPCPDDT | 301 | P33121 | |
| ISSCDTSDTEGPVPV | 681 | Q8N556 | |
| SEVSLPSDPSCVEEI | 346 | P51816 | |
| ELLQEDTPSTTECVS | 201 | A6NHR8 | |
| PVAQTESPCDLSSIV | 346 | Q12802 | |
| TVVLDEPTSGVDPCS | 3996 | Q86UQ4 | |
| DIIPSPTDTSCRQET | 1416 | O60306 | |
| EPDECTLLSPSQSDL | 226 | A6NLC5 | |
| TSDSAVSIPEDCPVG | 1421 | Q9H251 | |
| DQSIDDSTPCISVVA | 61 | Q9Y222 | |
| PPDVSCVDVDTNTIS | 481 | Q7Z401 | |
| SPTCPFREESQDTLT | 1286 | Q7Z401 | |
| PPDICQVVEVTTESD | 196 | P14316 | |
| NCSPTIPASNTADEE | 2456 | Q14571 | |
| QEQSCSLEPSAPEDL | 841 | Q9ULE6 | |
| IQTPSVCSDSLESPD | 76 | Q13886 | |
| PETLKSCETVTEEPS | 321 | Q6ZRR7 | |
| LNIQEPCSPATSSEA | 41 | Q03112 | |
| APCATSSPVTQDDLQ | 31 | P35228 | |
| PSIVSPITCLSEAEE | 256 | Q8IYW4 | |
| LSEEEPCTSTAIASP | 501 | Q9Y2X3 | |
| QCDETPPTSVSESAP | 2141 | P46821 | |
| ETVSILCSTQSNPDP | 341 | P20916 | |
| QEPLDDPTCIDTSET | 276 | Q96JK9 | |
| ELHCPSIEPIANTST | 601 | Q7Z3F1 | |
| CSPSPASQEDLESEI | 236 | Q03014 | |
| PVETCSIPRTASDTD | 356 | Q13480 | |
| SSVTEPCPDSGEQLQ | 566 | Q4FZB7 | |
| ASACTPESPQEELLS | 1116 | Q9P266 | |
| DCIPSLDSSQSTPTE | 101 | Q8N3X6 | |
| EAESQPCTSTLPREV | 181 | Q6ZN17 | |
| NLSENSCPPSEVSDT | 221 | O95786 | |
| CFLSQIPTPDSEETL | 2931 | Q5CZC0 | |
| KPVEEPADTSCQVDT | 321 | A6NKB5 | |
| VLSCVSPDNANSPEV | 1501 | Q9HCM2 | |
| TPCCSEDTIPSQVSD | 511 | O43312 | |
| VADITSTCPTGPDSE | 671 | Q6P3R8 | |
| PVQTLEFTCESPVSA | 331 | Q8N8W4 | |
| EVSVCTADSRDPTPQ | 1116 | Q9ULI4 | |
| PSDDLNATCVEPTEL | 206 | Q8N7C0 | |
| SPNCPSEDVVITPES | 346 | P16871 | |
| DTNCPPTIDSVTETL | 1071 | A8MYU2 | |
| RELFQTPCTDNPTTD | 1836 | P46013 | |
| CESPPLEVVDTTAST | 2706 | P46013 | |
| PLEDQCITASDTPVV | 341 | O75167 | |
| CPETTSQALPAFTTE | 101 | Q96FE7 | |
| PEITNVTQTCFDPDS | 476 | Q13219 | |
| SVQPCSEEVSTPQDS | 1766 | P42694 | |
| LSDSLPPVCDTVATD | 231 | Q9HCI7 | |
| SCPSAQVSPAVDSDL | 1041 | P63135 | |
| EEEQSPSDNSECSRP | 256 | A6NMN3 | |
| DASDVLTTEDPQCPQ | 1081 | Q27J81 | |
| SSEPSPTEVDVSRQC | 736 | Q6PIJ6 | |
| CQLPEDVDPTSVTSA | 126 | Q9UBY9 | |
| EPNVISSPAECSLEL | 1686 | Q96QU1 | |
| TQSPDNLTCTETPLV | 476 | P24394 | |
| PPAEVATTNEERSCS | 1876 | Q9Y2F5 | |
| VPVEEVDSPDSCQVS | 1061 | Q9BWV1 | |
| VVCDSNPTSDPTGTA | 36 | P23435 | |
| TENEDESPFICSQPR | 261 | O43497 | |
| ASAPPEEDCTSVTDL | 121 | P16070 | |
| CPSAQVSPAVDSDLT | 171 | P61566 | |
| SCPSAQVSPAVDSDL | 281 | P61570 | |
| SCPSAQVSPAVDSDL | 281 | Q69384 | |
| CPSAQVSPAVDSDLT | 171 | P61567 | |
| TDIVATVENEEPSPC | 231 | Q13698 | |
| TVENEEPSPCARTGS | 236 | Q13698 | |
| VQQTPASCPLDSDLS | 236 | P25686 | |
| AEIFTTLSCEPDIPN | 361 | Q9Y2H6 | |
| PDTQELADVSSVCTP | 396 | A2RUB6 | |
| ITSENTCKDPESNEP | 111 | Q5VVM6 | |
| GSVEPESDCSQTVSP | 236 | Q6UXB0 | |
| SVLEQESPASPSESC | 286 | P15408 | |
| CSDAEGTAVAPPTVT | 561 | P08519 | |
| ETGETCISANPSSVP | 1331 | P05997 | |
| QATPSPCSEIDTVGT | 46 | Q9NY43 | |
| CPSAQVSPAVDSDLT | 281 | P61565 | |
| CPSAQVSPAVDSDLT | 171 | Q9HDB8 | |
| TLETDDTTICSDRPP | 351 | Q6VMQ6 | |
| TDLDVPTEAVTCQPQ | 76 | Q99750 | |
| LSCELEPPSESASNT | 641 | Q12967 | |
| TISCPVPADEQTECT | 521 | Q71RC2 | |
| CAQEEPEVTTPASTI | 1011 | O15021 | |
| TSDPTDIPVVCLESD | 56 | O43504 | |
| SATSHPVSCQEPIDE | 1181 | Q8TEP8 | |
| FPTTEPGETSESCLE | 2281 | Q8TEP8 | |
| TESAATPPETCVGVA | 691 | Q8NEP3 | |
| PCSPTSVSDVDSDAL | 1011 | Q76NI1 | |
| SEVTSCPETSCLPTI | 161 | A8MX34 | |
| SCPSAQVSPAVDSDL | 281 | Q902F9 | |
| EFQSTEPEQSCADTP | 356 | Q9Y238 | |
| TSQDLLCEIEDSPSP | 831 | Q9Y238 | |
| APPTEVTICQSSEVS | 641 | Q5VT52 | |
| LTSCTETSDPLPTNE | 316 | O43432 | |
| FSALIEDSIPTCSPE | 2396 | Q8TDX9 | |
| QTRSPECTHESPLET | 236 | P20648 | |
| ETCETPDPNSINITA | 611 | P19022 | |
| VLECEPASEPSSFTV | 351 | Q9Y5R6 | |
| QESCTIPVQEDESPL | 171 | Q99558 | |
| PCSEEISDTSQEPSP | 556 | Q9BVI0 | |
| PVDNSTPVTTSTEAC | 1361 | Q685J3 | |
| TPLCENGPITSEDET | 251 | Q8NHP6 | |
| LEDATSPDSGPTVVC | 1166 | Q9P2F6 | |
| RPCESVSSSVQLPED | 191 | Q93008 | |
| DSERESVTTPGPATC | 861 | Q6WKZ4 | |
| FSVEESSTTPCPLLT | 711 | Q12872 | |
| TPASETLEDPCRTES | 196 | Q9Y6A5 | |
| VDSASVPETPLDCEV | 266 | Q9BUD6 | |
| STEYQCIPDSTIPQE | 406 | Q504Y2 | |
| ENPVDITLPSEECTT | 956 | Q14DG7 | |
| SEDEDVIPATQCLTP | 1001 | Q13428 | |
| QPKPDTEQASDSCLE | 116 | Q96S42 | |
| TADFTASEEPPCIIA | 236 | P28749 | |
| VESSPAADTTELSPC | 836 | O14827 | |
| CTPPSFEEATTASIA | 511 | O60331 | |
| QTPCEEVSESALNPQ | 131 | Q6PI26 | |
| LNIPDTATETQCSVP | 166 | Q92844 | |
| PSASSVCVAQDPEQL | 1076 | Q6ZUB1 | |
| ATEAVILTCDPETPD | 161 | Q13046 | |
| LEEESPSEGCPSSEI | 376 | Q5SWA1 | |
| PETRQSEHPELCSET | 1236 | Q13018 | |
| EPVSPCSSVNSEASL | 166 | Q99941 | |
| AAEESEPESVCSTPL | 181 | Q9UPV9 | |
| IDSECTVVQPSPGSQ | 2426 | A4UGR9 | |
| TPDQYSLCEVSVTPE | 646 | Q9Y4G8 | |
| SSPPEVDTCINEDVE | 156 | Q9NNX1 | |
| QNPSTLVSTLCEAEP | 6 | Q5GJ75 | |
| ECQTSLETSIFTPSP | 571 | Q92574 | |
| QAESTALPPCELETT | 566 | Q9P243 | |
| ALPPCELETTVVSSS | 571 | Q9P243 | |
| PSLSVLSVCTEESSP | 341 | Q9NZ09 | |
| NSPTPTEEGECQSLV | 136 | Q68D42 | |
| PPTTQSELDSLDLCD | 636 | O75970 | |
| IPEDTPENTETASVC | 581 | Q9UHI7 | |
| EEGELDSCPTITVSP | 66 | Q8NER1 | |
| QDTAETPCPLTSHVD | 131 | Q2MJR0 | |
| IPSPACASEASLEVT | 226 | Q8IV42 | |
| ISCAEEEPPSSALAS | 221 | Q9P2H5 | |
| PEVEAEQPLCSSQSQ | 1406 | Q8TEQ6 | |
| IEECSSLPVFPTNDL | 1561 | O60281 | |
| FTTSDDTPCQEQPKE | 46 | Q9H8N7 | |
| NCSNIEEITPPSISA | 396 | P08922 | |
| TPTQDAPETEACDET | 1071 | O95359 | |
| ESPCSRLAQTTPVDS | 881 | Q2KHR2 | |
| TVTLVCNTPNEAPSD | 341 | Q9BZZ2 | |
| QCTVDSEPPAELALS | 1366 | Q9BZZ2 | |
| DTPCLIIEDSQPESQ | 16 | Q12888 | |
| GSEVEEIPETPCESQ | 661 | Q12888 | |
| PIVECQECETEVSPS | 1276 | Q12888 | |
| ADDVTSVLFSPSCPT | 51 | Q7Z5U6 | |
| TATCPESSEEPICVS | 1211 | Q6AHZ1 | |
| CSPASSPDLTLEDVI | 1331 | Q4KWH8 | |
| SSDAICEDRDPPATQ | 161 | P43489 | |
| TDESSDDLCTVQIPT | 236 | Q9UIA9 | |
| VLTHPNTPSQECDES | 141 | Q8N9F8 | |
| ESAEPSQAPCSETSE | 286 | Q8TD55 | |
| SQAPCSETSEAAPRE | 291 | Q8TD55 | |
| PPECSTVVSTAVDSL | 11 | Q96LJ8 | |
| VVPTAPDTEADNCIV | 371 | Q92508 | |
| TNSPAIPLETSACQD | 626 | Q8NAP3 | |
| IPLETSACQDIPTSA | 631 | Q8NAP3 | |
| PVVSEENALSPNCTS | 261 | Q9H0M0 | |
| PNCTSTTVEDPPVQE | 271 | Q9H0M0 | |
| TPSEEEQPISVNACL | 981 | Q5T5U3 | |
| DQECIPCTKQTPTSE | 101 | Q9HAV5 | |
| TQPLNPILEDDCSST | 211 | Q9HAV5 | |
| TREPEEITEEPSACS | 226 | O43309 | |
| VRSCPEAPTSDTASD | 301 | Q01664 | |
| EDVLTQIDSEPECPS | 1251 | Q9ULM3 | |
| SEPSTADTVVPITCA | 676 | Q7Z3T8 | |
| PITCAIDSTADPQVS | 686 | Q7Z3T8 | |
| ETPAETPTTAEACSP | 201 | Q9NUA8 | |
| ELSDVSNDPTTSVCV | 906 | Q7Z570 | |
| SSCEVALSPSVNTEP | 351 | Q8N8K9 |